Martin Dunbar Selected Research

Martin Dunbar Research Topics

5	Neoplasms (Cancer) 01/2022 - 04/2015
4	Hematologic Neoplasms (Hematological Malignancy) 01/2017 - 10/2016
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2023 - 11/2021
3	Non-Hodgkin Lymphoma (Lymphosarcoma) 03/2017 - 01/2017
3	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2017 - 01/2016
2	Lung Neoplasms (Lung Cancer) 01/2022 - 11/2021
2	Nausea 01/2022 - 04/2015
2	Fatigue 01/2022 - 04/2015
2	Pain (Aches) 11/2020 - 10/2015
2	Infections 01/2018 - 01/2016
2	B-Cell Lymphoma (Lymphoma, B Cell) 01/2018 - 01/2017
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 02/2017 - 10/2016
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2021
1	Disease Progression 10/2018
1	Respiratory Insufficiency (Respiratory Failure) 01/2018
1	Carcinoma (Carcinomatosis) 01/2018
1	Sepsis (Septicemia) 01/2018
1	Breast Neoplasms (Breast Cancer) 01/2018
1	Multiple Myeloma 11/2017
1	Lymphoma (Lymphomas) 10/2016
1	B-Cell Leukemia (Leukemia, B Cell) 10/2016
1	Drug-Related Side Effects and Adverse Reactions 01/2016
1	Chronic Pain 10/2015
1	Brain Neoplasms (Brain Tumor) 04/2015
1	Hypokalemia 04/2015
1	Hyponatremia 04/2015

11	venetoclaxIBA 01/2018 - 01/2016
6	veliparibIBA 01/2022 - 04/2015
4	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2022 - 10/2018
3	Proteins (Proteins, Gene)FDA Link 10/2023 - 01/2017
3	PlatinumIBA 11/2021 - 10/2018
2	Carboplatin (JM8)FDA LinkGeneric 01/2022 - 01/2021
2	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 10/2018 - 01/2018
2	Cytochrome P-450 CYP3A InhibitorsIBA 02/2017 - 01/2017
1	ErbB Receptors (EGF Receptor)IBA 10/2023
1	telisotuzumab vedotinIBA 10/2023
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 10/2023
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2022
1	Alanine Transaminase (SGPT)IBA 01/2022
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2022
1	Death Domain ReceptorsIBA 01/2022
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2022
1	LigandsIBA 01/2022
1	Biomarkers (Surrogate Marker)IBA 11/2021
1	NivolumabIBA 11/2021
1	Etoposide (VP 16)FDA LinkGeneric 01/2021
1	ABT-767IBA 10/2018
1	Cytochrome P-450 CYP3AIBA 02/2017
1	posaconazole FDA Link 02/2017
1	Antifungal AgentsIBA 02/2017
1	Rilpivirine (TMC-278)IBA 01/2016
1	Antiviral Agents (Antivirals)IBA 01/2016